Many mammalian genes are clustered on the genomes, and hence the genes in the same cluster can be regulated through a common regulatory element. We indeed showed previously that the perilipin/PEX11alpha gene pair is transactivated tissue-selectively by PPARgamma and PPARalpha, respectively, through a common binding site. In the present study, we identified a gene, named GSPA, neighboring a canonical PPAR target, acyl-CoA oxidase (AOX) gene. GSPA expression was induced by a peroxisome proliferator, Wy14,643, in the liver of wild-type mice, but not PPARalpha-null mice. GSPA and AOX share the promoter and two peroxisome proliferator-response elements. GSPA mRNA was also found in the heart and skeletal muscle, as well as 3T3-L1 cells. GSPA encodes a protein of 161 amino acids that is enriched in 3T3-L1 cells. Even other gene pairs might be regulated through common sequence elements, and conversely it would be interesting how each gene is aptly regulated in clusters.
Many mammalian genes are clustered on the genomes, and hence the genes in the same cluster can be regulated through a common regulatory element. We indeed showed previously that the perilipin/PEX11alpha gene pair is transactivated tissue-selectively by PPARgamma and PPARalpha, respectively, through a common binding site. In the present study, we identified a gene, named GSPA, neighboring a canonical PPAR target, acyl-CoA oxidase (AOX) gene. GSPA expression was induced by a peroxisome proliferator, Wy14,643, in the liver of wild-type mice, but not PPARalpha-null mice. GSPA and AOX share the promoter and two peroxisome proliferator-response elements. GSPA mRNA was also found in the heart and skeletal muscle, as well as 3T3-L1 cells. GSPA encodes a protein of 161 amino acids that is enriched in 3T3-L1 cells. Even other gene pairs might be regulated through common sequence elements, and conversely it would be interesting how each gene is aptly regulated in clusters.
Recent analyses of human and other mammalian genomes have revealed
that unexpectedly a large number of protein-coding genes are
clustered [1], being arranged head-to-head, tail-to-head, or tail-to-tail. More recent comprehensive studies
[2] revealed that more than 60% of the mouse genome is
transcribed into RNA, often for both strands in the same regions.
Many of the RNA products do not seem to code for proteins
[3], and most of such noncoding RNAs are yet uncharacterized.Given such clustered arrangements of transcribed regions, it would
be inferred that two or more clustered genes (or transcriptional
units) are possibly regulated by common cis-elements in
considerable number of instances. Clustered genes with related
functions formed by gene duplication, for example, the β-globin gene cluster [4] and albumin/α-fetoprotein gene pair [5], have been known to be regulated by common enhancers. However, it is expected that even functionally
and structurally unrelated genes can be regulated by a common
mechanism, simply because a regulatory element for one gene is
located close to the other in a cluster. We have indeed reported
that the genes of PEX11α, a peroxisome biogenesis factor,
and perilipin, a lipid droplet-coating protein, are regulated by
peroxisome proliferator-activated receptor (PPAR) subtypes through
a common cis-element [6]. The PEX11α and perilipin genes are arranged in tandem in this order, with the same
transcriptional orientation. A common peroxisome
proliferator-response element (PPRE), which serves as a binding
site of PPAR/RXR heterodimer [7], is located within the spacer region, 8.4 kb downstream of the PEX11α
promoter, whereas 1.9 kb upstream of the perilipin promoter.
In the liver, this PPRE confers the action of PPARα,
leading to the induction of PEX11α by the PPARα
ligands, peroxisome proliferators. On the other hand, in the
adipose tissue, the same PPRE is recognized by PPARγ,
hence resulting in the expression of perilipin dependent on
adipogenesis. The differential regulation of these genes is
probably attained by the differential expression of the two PPAR
subtypes in the liver and adipose tissue, and also by the
differences in the positions and/or distances of the PPRE
relative to the promoters. Differential interactions with other
transcriptional factors also seem important [8]. One of such factors is NF-I, which is required for the activation of perilipin
gene by PPARγ, but not for that of PEX11α gene by
PPARα.To examine the generality of such common regulatory mechanisms for
clustered genes, we searched in the mouse EST databases for
transcripts that start from positions close to the promoters of
known PPAR target genes. We report here the identification of a
gene that is transcribed in the opposite orientation from the
promoter of acyl-CoA oxidase (AOX) gene, a canonical target of
PPARα. This gene also shares the PPARα target
sites with the AOX gene.
MATERIALS AND METHODS
Construction of reporter plasmids
We first searched for a gene that is mapped close to
established PPAR target genes in the mouse genome. Using NCBI
Mouse Genome Resources, we found a gene, named GSPA in this work,
which is located just upstream of the AOX gene in the opposite
orientation (see “results”). For constructing reporter plasmids,
we amplified appropriate DNA fragments by PCR from a mouse BAC
clone, RP23-174D24. For GSPA, fragment encompassing positions
−161 through 483 (for position numbers, see
Figure 1(b)), which contained the basal promoter, exon
1, and the early part of intron 1, was amplified with primers 1F,
5′-AGGAGGTGGCGACAGAAGTG-3′ and 1R,
5′-CAACGACAATGAACCGTCTCC-3′. This fragment was inserted
into the EcoRV site of pBluescript KS(-) (Stratagene), yielding
plasmids, pBSfr1-1 and pBSfr1-2. The fragment was inserted in
opposite orientations in these plasmids, the HindIII site of the
multicloning region being on the upstream and downstream sides
relative to the insert, respectively. Another genomic fragment,
encompassing from the position 340 bp upstream of intron
1/exon 2 boundary to the 39th position of exon 2 of GSPA, was
amplified using a primer pair 2F,
5′-ACCTCTGCAGGCCCATGCTG-3′ and 2R,
5′-ACCAGGATCCAAATCGTTGGC-3′. This fragment was inserted
into the EcoRV site of pBluescript-KS(-), yielding pBSfr2, in
which the HindIII site of the vector is located on the upstream
side. The insert of pBSfr1-2 was cleaved out with HindIII and
SalI, and inserted between the HindIII and SalI sites of pBSfr2.
The resulting plasmid, pBSfr1/2, contains GSPA sequences for the
basal promoter, exon 1, parts of intron 1, one of which containing
the two putative PPREs, and a part of exon 2 before the putative
initiation codon. A stretch of 5133 bp in the middle portion
of intron 1 was removed, to reduce the plasmid size. It was
expected that transactivation by PPARα would be observed
even with this partially deleted construct, if the putative PPREs
have sufficient functions as in the ratAOX gene. pBSfr1/2 was
cleaved with ApaI, blunt-ended with Klenow fragment, and then
cleaved with BamHI. The GSPA-derived sequence was isolated and
inserted between the SmaI and BglII sites of a promoter-less
luciferase reporter vector, pGVBΔ, in which the SV40 small
T intron was eliminated from pGVB (Toyo Ink) to prevent aberrant
splicing [9]. The final product, pGSPAluc, was used for the reporter assay to monitor the activation by PPARα. For
constructing the AOX reporter, the insert of pBSfr1-1 was cleaved
out with SmaI and HindIII, and inserted between
the SmaI and HindIII sites of pGVBΔ, yielding pMmAOXluc,
where the mark “Mm” was attached for discriminating the
construct from the ratAOX reporters already described [10]. In this construct, the genome-derived sequence was inserted in the
vector, in the same orientation as that of AOX, that is, reverse
to that of GSPA. A truncated reporter plasmid, pMmAOXBluc, was
constructed by removing the region between positions 21 and 483
from pMmAOXluc, exploiting an internal KpnI site (see
Figure 1(b)). pMmAOXBluc lacked both putative PPREs,
while retaining the sequence corresponding to the ratAOX minimal
promoter [11].
Figure 1
Identification of GSPA in the mouse genome. (a) GSPA is
positioned closely adjacent to the AOX gene in the opposite
orientation. Exons are shown with boxes and numbered. For AOX
gene, only exon 1 is presented, starting from the minor
transcriptional initiation site. Open, filled, and gray areas
indicate noncoding, GSPA-coding, and AOX-coding regions,
respectively. Closed circles denote two PPRE-like motifs. In the
enlarged view, exon 1 of each gene is depicted together with the
transcriptional orientation shown with horizontal arrow. (b)
Alignment of mouse and rat genomic sequences around the
transcriptional initiation sites of GSPA and AOX genes including
the two PPRE-like motifs. Nucleotide numbers are shown starting
from the transcriptional initiation site of GSPA, with increasing
numbers in the direction of GSPA transcription. Exon 1 of GSPA,
mouse AOX, and rat AOX are boxed with solid, broken, and chain
lines, respectively. Major and minor transcriptional initiation
sites of the genes are indicated with large and small arrows,
respectively, pointing the direction of transcription. Closed
circles, asterisks, and dashes denote two PPRE-like motifs,
nucleotides conserved between mouse and rat, and gaps,
respectively. Horizontal arrows indicate sites of PCR primers 1F
and 1R, used for reporter construction. (c) cDNA and predicted
amino acid sequences of mouse GSPA. Nucleotides and amino acids
are numbered taking the first letter of the predicted initiation
codon and initiator methionine as 1, respectively. Nucleotides of
the 5′ noncoding region are indicated with negative numbers.
Amino acids are presented with single-letter codes, asterisk
indicating a stop codon. Triangle denotes the position of intron
insertion. Horizontal arrows and underline indicate the sites of
primers for RT-PCR and polyadenylylation signal, respectively.
Site-directed mutagenesis
Mutant reporter constructs in which the putative PPREs, PPRE-1,
PPRE-2, or both, were destroyed were created by the PCR-based
overlap extension method [12]. The following oligonucleotides carrying base substitutions in the PPRE-1 or PPRE-2 portion were
used: mutPPRE-1F, 5′-AAAGGGTAACctcgagAAGGTTACGT-3′; mutPPRE-1R, ACGTAACCTTctcgagGTTACCCTTT-3′; mutPPRE-2F, 5′-AAAGCAAGGTAAAAGcgatAGGGAC-3′; and mutPPRE-2R, 5′-GTCCCTatcgCTTTTACCTTGCTTT-3′, where underlines denote the sequences corresponding to PPREs, small letters representing mutated bases.
Two other primers designed so as to match the vector sequences
outside the inserts were also used: pGVB-uni,
5′-TGTATCTTATGGTACTGTAACTG-3′, positioned upstream of
the polylinker region; Luc-rev, 5′-ATGTTTTTGGCGTCTTCCA-3′, positioned just downstream of the luciferase initiation codon in the antisense direction. For
PPRE-1 mutation in the GSPA reporter, the first PCR was performed
using primer pairs, pGVB-uni/mutPPRE-1R and mutPPRE-1F/Luc-rev,
employing pGSPAluc as a template. The PCR products were mixed,
denatured, reannealed, and subjected to the second round of PCR,
using a primer pair, pGVB-uni/Luc-rev. The product was digested
with PstI, and used to replace the corresponding PstI/PstI region
of pGSPAluc, yielding the PPRE-1 mutant construct,
pGSPA(mutPPRE-1)luc. For PPRE-1 mutation in the AOX reporter,
oligonucleotide pairs pGVB-uni/mutPPRE-1F and mutPPRE-1R/Luc-rev
were used as primers, and pMmAOXluc as a template, in the first
round of PCR. The second PCR was performed as above, and the
product was used to replace the SmaI/HindIII region of pMmAOXluc,
yielding pMmAOX(mutPPRE-1)luc. The PPRE-2 mutants,
pGSPA(mutPPRE-2)luc and pMmAOX-(mutPPRE-2)luc, were
constructed by similar procedures as above, except for using
mutPPRE-2F and mutPPRE-2R primers instead of mutPPRE-1F and
mutPPRE-1R, respectively. The double mutation constructs,
pGSPA(mutPPRE1/2)luc and pMmAOX(mutPPRE1/2)luc, were created by
mutating PPRE-2 of pGSPA(mutPPRE-1)luc and
pMmAOXluc-(mutPPRE-1)luc. All PCR procedures were performed using
KOD-plus DNA polymerase (Toyobo), and presence of desired
mutations and absence of unexpected mutations were confirmed by
DNA sequencing.
Reporter assays
HeLa cells were cultured in 12-well plates and transfected with
DNA by a calcium phosphate method. For each well, transfection was
performed using plasmid mixtures composed of
0.8 μg of a reporter plasmid, 0.1 μg of a
PPARα expression vector, pNCMVPPARα, as necessary,
and 0.2 μg of pCMVβ as an internal control. Total
amount of DNA was kept at 1.5 μg/well by the addition of
appropriate amount of an empty vector, pCMX. Other experimental
conditions were as described previously [6].
Reverse transcription (RT)-PCR
Expression of GSPA in the tissues of wild-type and
PPARα-null mice was estimated by RT-PCR. Mice were fed
ad libitum with a laboratory chow containing or not
containing a peroxisome proliferator, Wy14, 643. RNA from
undifferentiated and differentiated 3T3-L1 cells were also
analyzed. The following primers were used: GSPA-F,
5′-GAAGCACACTGCGAACATTTG-3′; and GSPA-R,
5′-TGTCACTGGGAATCGATTGAG-3′. Other experimental
conditions and primer sequences were as described previously
[13].
Western blotting
Expression of GSPA protein (GSPAp) in mouse tissues as well as
3T3-L1 preadipocytes and adipocytes were estimated by Western
blotting. An antibody to GSPAp was raised in rabbits, using
glutathione S-transferase (GST)-fused GSPAp expressed in
Escherichia coli. Proteins were separated by SDS-PAGE
using a 13% polyacrylamide gel. Other experimental procedures
were as described previously [13].
Electrophoretic gel-mobility shift assay (EMSA)
A 32P-labeled double-stranded oligonucleotide containing the
ratAOX PPRE-1 was used as a probe, as described in
[10]. Oligonucleotides encompassing mouseAOX/GSPA PPRE-1, PPRE-2, and their mutant versions were used as
competitors. They were composed of the following sequences and the
respective complements: PPRE-1, 5′-AAAGGGTAACAGGACAAAGGTTACGT-3′; mutPPRE-1, 5′
-AAAGGGTAACctcgagAAGGTTACGT-3′; PPRE-2, 5′- AAAGCAAGGTAAAAGGTCAAGGGAC-3′; and mutPPRE-2, 5′-AAAGCAAGGTAAAAGcgatAGGGAC-3′. Assays were carried out as described in [10], using a maltose binding protein (MBP)-fused PPARα and GST-fused RXRα.
RESULTS
Identification in silico of a gene sharing
the promoter with the AOX gene
We searched for a gene that is located near a known PPAR target
gene in the NCBI mouse genome map. Several EST clones derived from
the same transcript (eg, AK009156 (Riken 2310004N24)) were found
to be mapped in the upstream region of AOX gene (Acox1;
GI:66793428) (Figure 1(a)), on the mouse chromosome
11. The gene corresponding to Riken 2310004N24 and the
AOX gene seem to share the promoter, being transcribed in the
opposite orientations. Hence, we named the gene corresponding to
Riken 2310004N24, GSPA (a gene sharing a promoter with the AOX gene). GSPA is constituted by four exons, spanning 17, 268 bp. Upon closer inspection of
the promoter region, the first exons of GSPA and AOX overlap to
each other (Figure 1(b)), according to the RefSeq of
AOX mRNA (NM 015729.2). However, a vast majority of mouseAOX EST
clones start at more downstream positions (eg, AK054446.1;
Figure 1(b)), and hence, with regard to the major AOX
start site, the GSPA and AOX genes are arranged head-to-head,
separated by a small space. The nucleotide sequences of the
GSPA/AOX promoter regions are well conserved between mouse and rat
(chromosome 10). The major transcription start site of the ratAOX
gene has been mapped more downstream as compared with that of the
mouseAOX gene, with several minor initiation sites positioned
more upstream [14], close to the major start sites of mouseAOX gene. GSPA has an ORF starting from the first ATG triplet
located in exon 2, encoding a hypothetical protein of 161 amino
acid residues (BAB26112; Figure 1(c)), which is the
longest ORF predictable from the cDNA sequence.
GSPA is a target gene of PPARα
The PPRE of ratAOX gene is best characterized among others, being
located 560 to 572 nucleotides upstream of the major cap site,
corresponding to PPRE-1 in Figure 1(b) [11, 15].
This element is conserved in the mouse genome, with a single
nucleotide deviation. These elements of rat and mouse have one and
two mismatches as compared with the consensus PPRE sequence
(AGGTCA N AGGTCA) [7], respectively. In the mouse genome, another PPRE-like sequence, PPRE-2, was found at positions 161 to
173 nucleotides upstream of the AK054446.1 start site. This
element was conserved in the rat with a single base mismatch, and
the deviation from the PPRE consensus sequence is one for the
mouse and two for the rat, respectively. While PPRE-1 is located
in the first intron with respect to GSPA, PPRE-2 encompasses the
exon 1/intron 1 junction of GSPA. Previous studies established
that the ratAOX gene is regulated by PPARα through the
PPRE-1 [10, 11, 15], while the role of PPRE-2 was not noted.
Because the mouseAOX gene is also regulated by PPARα,
PPRE-1 and/or PPRE-2 were likely to serve as functional PPREs, and
it was further expected that GSPA is also regulated by the same
mechanism through the same PPRE(s).To examine this possibility, we studied the induction of GSPA
expression by a peroxisome proliferator, Wy14,643, in comparison
with that of AOX. Liver RNA was prepared from the wild-type and
PPARα-knockout mice, fed with or without Wy14,643, and
analyzed for gene expression by RT-PCR (Figure 2). In
the wild-type mice, GSPA was markedly induced by the drug, whereas
in the PPARα-null mice, no induction was observed. For
AOX, PPARα-dependent induction by Wy14,643 was confirmed
as reported previously [6, 16]. Thus, GSPA is a bona fide target of PPARα.
Figure 2
GSPA is a target gene of PPARα. RT-PCR was
performed with RNA samples from two animals for wild type or
PPARα-null mice treated or not with Wy14,643. A ribosomal
subunit gene, 36B4, was used as a control unaffected by
Wy14, 643. PCR was performed for 30, 22, and 26 cycles for GSPA,
AOX, and 36B4, respectively. Other experimental conditions were as
described in [13].
Both PPRE-1 and PPRE-2 are involved in
the transcriptional regulation of GSPA and AOX
To assess the roles of these putative PPREs, we performed gene
reporter assays with respect to both AOX and GSPA transcriptional
orientations. For AOX, an upstream region containing both PPRE-1
and PPRE-2, as well as the basal promoter region (nucleotide
positions 483 to −161 in Figure 1(b)) was placed
upstream of the luciferase reporter gene
(Figure 3(a)). On the other hand, for GSPA, a region
encompassing the basal promoter starting at −161, exon1, intron
1, and the early part of exon 2 up to 8 nucleotides before the
initiation codon was inserted in a luciferase reporter
vector. The inserts were oriented so that transcription would
occur in the same directions as those of natural AOX and GSPA,
respectively. Mutants were created in these reporter plasmids, in
which one of the half-sites was broken for PPRE-1, PPRE-2, or
both. For AOX, a reporter construct carrying only the minimal
promoter (positions 21 to −161 in Figure 2),
pMmAOXBluc, was also created. In reporter assays with HeLa cells,
the reporter expression was significantly enhanced by
cotransfection of a PPARα expression vector, which was
further promoted by the addition of Wy14,643 for both AOX and GSPA
(Figures 3(b) and 3(c)). The activation by
PPARα was significantly reduced by a single mutation of
either PPRE-1 or PPRE-2, and further diminished by the double
mutations involving both PPRE-1 and PPRE-2, for both AOX and GSPA.
The residual transactivation by PPARα and Wy14,643 of the
double mutant construct was possibly due to yet uncharacterized
element(s) in the genome region studied, or cryptic PPRE(s) in the
vector. These results suggest that PPRE-1 and PPRE-2 function in
the transcriptional activation by PPARα for both AOX and
GSPA, synergistically. It should be noted that the luciferase
activity of pMmAOXluc was about 10 times higher than that of
pGSPAluc, for the values in the presence of both PPARα and
ligand. Thus, the shared promoter functions much more efficiently
for transcription in the direction of AOX than that of GSPA. This
result was consistent with that of RT-PCR (Figure 2),
in which GSPA required more cycles of PCR as compared with those
for AOX, to obtain comparable intensities of signals.
Figure 3
Both PPREs contribute to the PPARα-dependent
transactivation of GSPA and AOX. (a) Schematic view of the
reporter constructs. Upstream and intron regions are depicted with
horizontally long boxes, whereas exons with vertically long gray
boxes. Nucleotide numbers correspond to those in
Figure 1(b). The −161/483 region was included in
common in both pGSPAluc and pMmAOXluc in opposite orientations.
Only parts of 5′ noncoding stretches of exon 2 of GSPA and exon
1 of AOX were included in the respective reporters. In pGSPAluc,
whole exon 1 that is noncoding and intron 1 were included, while a
5.1 kb region in the middle of intron 1 was omitted. pMmAOXBluc
was also prepared as to lack both PPRE-1 and PPRE-2, but retained
the GC-rich region. (b) and (c) Reporter assays for GSPA and AOX
expressions, respectively. pGSPAluc, pMmAOXluc, and their mutants
involving PPRE-1 (mutP1), PPRE-2 (mutP2), or both (mutP1/mutP2)
were transfected into HeLa cells with or without a PPARα
expression plasmid, and after transfection, the cells were
cultured in the presence or absence of Wy14, 643. For AOX, a
minimal promoter vector, pMmAOXBluc, was also employed. Letters
“pMm” are omitted from the names of plasmids in the figure. In
both (b) and (c), the luciferase activities are shown as relative
values, taking the values of respective wild-type constructs in
the absence of PPARα expression plasmid and Wy14643, as 1.
Mean values of three independent assays are given, together with
standard deviations. The actual mean luciferase activity values in
the presence of both PPARα and Wy14, 643 were 2.15×106 and 2.37×107 luciferase units for pGSPAluc and
pMmAOXluc, respectively.
PPARα/RXRα heterodimer binds to
both PPRE-1 and PPRE-2
To examine whether these putative PPREs are
recognized by PPARα/RXRα heterodimer, we performed
EMSA, using fusion proteins MBP-PPARα and
GST-RXRα. RatAOX PPRE was used as a probe, and the wild type as well as
mutant PPRE-1 and PPRE-2 were tested for the ability to compete
with the probe for binding. Under the experimental conditions,
PPARα alone did not exhibit a band with the probe, though
RXRα did, probably representing homodimeric binding
(Figure 4, lane 3). Mixed addition of PPARα
and RXRα yielded another band corresponding to the
heterodimer (lane 4). This band was efficiently competed by the
unlabeled probe itself, PPRE-1, and PPRE-2 (lanes 5, 6, and 8),
but not by the mutant sequence of PPRE-1 or PPRE-2 (lanes 7 and
9). Thus, both PPRE-1 and PPRE-2 served as efficient
PPARα/RXRα binding sites in vitro.
Figure 4
Both PPRE-1 and PPRE-2 serve as effective binding sites
for the PPARα/RXRα heterodimer. EMSA was performed
using MBP-PPARα and GST-RXRα expressed in
E coli, using the rat AOX PPRE (corresponding to
PPRE-1), as a probe. Competitors were rat AOX PPRE (unlabeled
probe; r1), mouse PPRE-1 (m1) or its mutant (m1M), and mouse
PPRE-2 (m2) or its mutant (m2M). Shifted bands with PPARα/RXRα heterodimer and RXRα homodimer are
indicated, together with that of free probe.
Expression of GSPA transcript and the protein product
PPARα is also abundantly expressed in mouse tissues other
than the liver, for example, the heart [15]. In addition, adipose tissue is a major site of PPARγ action.
Accordingly, we examined the expression of GSPA in the mouse heart
and skeletal muscle, as well as 3T3-L1 preadipocytes and
adipocytes, in comparison with AOX expression
(Figure 5(a)). By RT-PCR, the AOX transcript was found
to be induced by Wy14, 643 in the heart and skeletal muscle as in
the liver, being consistent with a previous result [13]. In 3T3-L1, AOX RNA was significantly increased upon differentiation.
The GSPA transcript was also found in all these tissues and cells,
at comparable levels as that in the liver. Fold induction of GSPA
RNA by Wy14,643 in the heart and skeletal muscle was smaller than
that in the liver, due to higher basal expression in the heart and
skeletal muscle. Similar levels of GSPA mRNA were detected for
differentiated and undifferentiated 3T3-L1 cells. Thus, the basal
expression of AOX and GSPA seems to be differentially regulated in
different tissues and cells, albeit directed by the common
promoter.
Figure 5
GSPA mRNA is expressed in a wide range of
PPAR-expressing tissues and cells, while GSPA protein is
exceedingly abundant in 3T3-L1 preadipocytes and adipocytes. (a)
RT-PCR of RNA samples from the mouse heart, liver, and skeletal
muscle, as well as 3T3-L1 preadipocytes (Pre) and adipocytes (Ad).
Wild-type mice were fed with or without Wy14, 643, two animals
being used for each condition. RT-PCR was performed as in
Figure 2. (b) Western blotting of protein samples from
the mouse heart and liver, as well as 3T3-L1 preadipocytes (Pre)
and adipocytes (Ad). Extracts prepared from HeLa cells transfected
with a GSPA-expression vector (G) and an empty vector (V) were
analyzed in parallel to reveal the band position of GSPAp. Ch and
Wy, tissue extracts from the mice fed normal chow or
Wy14, 643-containing diet, respectively. Anti-GSPAp antiserum was
used at 200-fold dilution. Membrane was reprobed with anti-lactate
dehydrogenase (LDH) antibody as a loading control. Other
conditions were as described previously [13]. All samples were analyzed in a single gel. Positions of size markers (in kd)
are shown on the right.
We next examined whether GSPA encodes a protein. For this purpose,
we raised an antibody to predicted GSPA protein product (GSPAp),
using a GST-GSPAp fusion protein expressed in E. coli as
an antigen. The antiserum recognized GSPAp effectively, judged by
the reactivity with both the fusion proteins of GSPAp with GST and
GFP (data not shown). Presence of GSPAp was examined by Western
blotting, for protein samples from the heart and liver of mouse
fed with or without Wy14, 643, as well as 3T3-L1 preadipocytes
and adipocytes. The antibody recognized an extra band for the
extract of HeLa cells transfected with a GSPA expression vector as
compared with that of the control cells (Figure 5(b);
lanes 1 and 2). We judged this band to be representing GSPAp,
although the estimated size (27 kDa) of the band was
apparently larger than the calculated molecular mass of GSPAp
(18.1 kDa). A band was detected for 3T3-L1 samples at the
same position with that of GSPAp, at similar levels in the
adipocytes and preadipocytes, consistent with the result of
RT-PCR. A much fainter band of the same size was also observed for
the heart and liver samples, apparently being induced by
Wy14, 643. On the other hand, a corresponding band was not
detected for skeletal muscle (data not shown). Thus, GSPA indeed
encodes a protein product, but the content of the protein is
highly variable among cell types, despite comparable mRNA levels.
DISCUSSION
In the present paper, we have identified a mouse gene, GSPA, as a
novel target of PPARα on the mouse genome. GSPA is located
closely adjacent to the AOX gene, transcribed in the orientation
opposite to the latter. The transcriptional start site of GSPA is
separated by less than 70 nucleotides from the predominant start
site of AOX, or the transcripts of these genes even overlap, with
regard to the minor AOX transcript. Hence, these genes are driven
by a common promoter, which is GC-rich, while lacking a TATA-box.
It has been pointed out that such TATA-less promoters often confer
bidirectional transcription from less defined initiation sites
[17, 18].GSPA and AOX also share the PPREs. Two PPREs, PPRE-1 and PPRE-2,
were found in the first intron of GSPA, whereas in the upstream
region of AOX major transcriptional start site. Both of them are
functional, acting synergistically in driving transcription of
both GSPA and AOX. In the previous studies on the ratAOX, only an
element corresponding to PPRE-1 was noted in gene reporter assays
[11]. As compared with the idealized sequence of nuclear receptor-binding half-site, AGGTCA, mouse PPRE-1 is deviated at
two positions, one in each half-site, whereas mouse PPRE-2 at only
one position. On the other hand, rat PPRE-1 deviates by only one
nucleotide from the consensus, while rat PPRE-2 carries two
mismatches in one of the half-sites. These differences in the
nucleotide sequences probably result in the different functions of
these elements in the transcriptional regulation in the two
species.This is the second example of PPRE(s) shared by two genes. In the
first case, the PEX11α/perilipin gene pair, the two genes
are oriented in the same direction, and each gene is activated by
PPARα and PPARγ, selectively in a tissue-specific
manner [6]. In contrast, in the present case, the two genes are oriented in the opposite directions, and both genes are
activated by PPARα. In view of the recent reports that
many mammalian genes are clustered in the genomes [1], and more than 60% regions of the mouse genome are transcribed
[2], any PPREs as well as other transcriptional
regulatory sites can be by chance positioned close to more
than two genes. Hence, even more cases of shared regulatory
elements would be found in future. Indeed, for example, a
bidirectional promoter has been recently reported for
Gabpα/ATP synthase coupling factor 6 genes [19]. If the neighboring genes are functionally related, they would be
adequately regulated by similar mechanisms through common
regulatory elements. Neighboring genes, however, might not
necessarily have related functions. In such situations, a pair of
genes must be regulated independently, and hence the influence of
a given regulatory element must be restricted for one gene,
whereas the other gene must appropriately be insulated from it.
Elements having functions similar to those of “insulators” or
“enhancer blockers,” which are usually imagined to function in
blocking long-range enhancer actions [20], might also be involved in more nearby regulatory interactions.Despite the sequence conservation in the GSPA/AOX promoter region
between mouse and rat, it is not clear at present whether GSPA is
transcribed into RNA in the rat. Although considerable number of
cDNA sequences apparently derived from this genomic region have
been deposited in the rat EST databases, most of them are
annotated to be oriented opposite to the mouseGSPA. In human, on
the other hand, an EST clone homologous to GSPA is found in the
database (BC047782). In addition, another EST sequence (AK097104)
has been deposited, which further extends than the mouseGSPA
cDNAs on the 3′ side, continuing into the exon sequences of
neighboring gene, CDK3. It seems doubtful whether the latter human
cDNA represents a physiologically relevant transcript. Sequence of
the promoter region of humanAOX is less conserved as compared
with the mouse and rat counterparts, neither PPRE-1 nor PPRE-2
being retained. HumanAOX is not likely to be induced by
peroxisome proliferators [21], though a potential PPRE sequence has been noted in a far upstream region [22].We found that GSPA is widely expressed in tissues where
PPARα plays a regulatory role, such as liver, heart, and
skeletal muscle. The dependence on PPARα ligand was less
significant in the heart and skeletal muscle than in the liver,
due to higher basal expression. GSPA is also expressed in 3T3-L1
cells, though apparently independent of differentiation. Hence, it
is not clear whether PPARγ is involved in the regulation
of GSPA expression in these cells. Thus, GSPA is possibly
expressed in even other tissues, though the expression may not be
activated by PPARs. On the other hand, we found significant
expression of the GSPA protein product in 3T3-L1 adipocytes and
preadipocytes. In the heart and liver, the protein abundance was
much lower, despite the comparable mRNA levels. Thus, GSPA
expression must also be regulated at a posttranscriptional level.What would be the function of GSPA? In the GSPAp amino acid
sequence, neither a known protein motif nor a predictable
membrane-spanning domain was noted. A GFP-fused version of GSPAp
expressed in HeLa cells were distributed throughout the cells,
without accumulating in any subcellular compartments (data not
shown), suggesting a cytosolic nature of the protein. Enrichment
of GSPAp in 3T3-L1 cells over other tissues seems promising for
the functional studies. It would be an interesting issue whether
the abundant expression of GSPAp is characteristic in the
adipocyte lineage. Other important questions would be how GSPAp
expression is posttranscriptionally regulated, and whether the
protein is accumulated in the liver, heart, and other tissues
under specific conditions. It should be noted that, for the
homologous human cDNAs, an even shorter protein sequence of 122
amino acid residues, 62% identical with the mouse sequence, is
predicted, due to an in-frame stop codon at a more upstream
position. Thus, it is questionable whether the function of GSPA is
conserved in human. The function of GSPA should carefully be
investigated also from an evolutionary point of view.
Authors: S Katayama; Y Tomaru; T Kasukawa; K Waki; M Nakanishi; M Nakamura; H Nishida; C C Yap; M Suzuki; J Kawai; H Suzuki; P Carninci; Y Hayashizaki; C Wells; M Frith; T Ravasi; K C Pang; J Hallinan; J Mattick; D A Hume; L Lipovich; S Batalov; P G Engström; Y Mizuno; M A Faghihi; A Sandelin; A M Chalk; S Mottagui-Tabar; Z Liang; B Lenhard; C Wahlestedt Journal: Science Date: 2005-09-02 Impact factor: 47.728
Authors: P Carninci; T Kasukawa; S Katayama; J Gough; M C Frith; N Maeda; R Oyama; T Ravasi; B Lenhard; C Wells; R Kodzius; K Shimokawa; V B Bajic; S E Brenner; S Batalov; A R R Forrest; M Zavolan; M J Davis; L G Wilming; V Aidinis; J E Allen; A Ambesi-Impiombato; R Apweiler; R N Aturaliya; T L Bailey; M Bansal; L Baxter; K W Beisel; T Bersano; H Bono; A M Chalk; K P Chiu; V Choudhary; A Christoffels; D R Clutterbuck; M L Crowe; E Dalla; B P Dalrymple; B de Bono; G Della Gatta; D di Bernardo; T Down; P Engstrom; M Fagiolini; G Faulkner; C F Fletcher; T Fukushima; M Furuno; S Futaki; M Gariboldi; P Georgii-Hemming; T R Gingeras; T Gojobori; R E Green; S Gustincich; M Harbers; Y Hayashi; T K Hensch; N Hirokawa; D Hill; L Huminiecki; M Iacono; K Ikeo; A Iwama; T Ishikawa; M Jakt; A Kanapin; M Katoh; Y Kawasawa; J Kelso; H Kitamura; H Kitano; G Kollias; S P T Krishnan; A Kruger; S K Kummerfeld; I V Kurochkin; L F Lareau; D Lazarevic; L Lipovich; J Liu; S Liuni; S McWilliam; M Madan Babu; M Madera; L Marchionni; H Matsuda; S Matsuzawa; H Miki; F Mignone; S Miyake; K Morris; S Mottagui-Tabar; N Mulder; N Nakano; H Nakauchi; P Ng; R Nilsson; S Nishiguchi; S Nishikawa; F Nori; O Ohara; Y Okazaki; V Orlando; K C Pang; W J Pavan; G Pavesi; G Pesole; N Petrovsky; S Piazza; J Reed; J F Reid; B Z Ring; M Ringwald; B Rost; Y Ruan; S L Salzberg; A Sandelin; C Schneider; C Schönbach; K Sekiguchi; C A M Semple; S Seno; L Sessa; Y Sheng; Y Shibata; H Shimada; K Shimada; D Silva; B Sinclair; S Sperling; E Stupka; K Sugiura; R Sultana; Y Takenaka; K Taki; K Tammoja; S L Tan; S Tang; M S Taylor; J Tegner; S A Teichmann; H R Ueda; E van Nimwegen; R Verardo; C L Wei; K Yagi; H Yamanishi; E Zabarovsky; S Zhu; A Zimmer; W Hide; C Bult; S M Grimmond; R D Teasdale; E T Liu; V Brusic; J Quackenbush; C Wahlestedt; J S Mattick; D A Hume; C Kai; D Sasaki; Y Tomaru; S Fukuda; M Kanamori-Katayama; M Suzuki; J Aoki; T Arakawa; J Iida; K Imamura; M Itoh; T Kato; H Kawaji; N Kawagashira; T Kawashima; M Kojima; S Kondo; H Konno; K Nakano; N Ninomiya; T Nishio; M Okada; C Plessy; K Shibata; T Shiraki; S Suzuki; M Tagami; K Waki; A Watahiki; Y Okamura-Oho; H Suzuki; J Kawai; Y Hayashizaki Journal: Science Date: 2005-09-02 Impact factor: 47.728
Authors: Shoba Shetty; Maria A Ramos-Roman; You-Ree Cho; Jonathan Brown; Jorge Plutzky; Eric S Muise; Jay D Horton; Philipp E Scherer; Elizabeth J Parks Journal: Endocrinology Date: 2011-11-01 Impact factor: 4.736